Is more always better? Low-dose pembrolizumab as a practical step toward more equitable triple-negative breast cancer care
Ann Oncol
.
2026 May;37(5):579-582.
doi: 10.1016/j.annonc.2026.02.005.
Epub 2026 Mar 5.
Authors
R Sacks
1
,
S Gandhi
2
Affiliations
1
Department of Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA.
2
Department of Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA. Electronic address: Shipra.gandhi@emory.edu.
PMID:
41786571
DOI:
10.1016/j.annonc.2026.02.005
No abstract available
Publication types
Editorial
Grants and funding
K08 CA279766/CA/NCI NIH HHS/United States